Logo image of DLX.DE

DELIGNIT AG (DLX.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DLX - DE000A0MZ4B0 - Common Stock

2.34 EUR
0 (0%)
Last: 12/18/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, DLX scores 5 out of 10 in our fundamental rating. DLX was compared to 12 industry peers in the Paper & Forest Products industry. DLX has an average financial health and profitability rating. DLX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DLX had positive earnings in the past year.
Each year in the past 5 years DLX has been profitable.
Of the past 5 years DLX 4 years had a positive operating cash flow.
DLX.DE Yearly Net Income VS EBIT VS OCF VS FCFDLX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.77%, DLX is in line with its industry, outperforming 58.33% of the companies in the same industry.
DLX has a Return On Equity (2.33%) which is comparable to the rest of the industry.
DLX has a worse Return On Invested Capital (2.11%) than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DLX is in line with the industry average of 5.21%.
The last Return On Invested Capital (2.11%) for DLX is well below the 3 year average (6.49%), which needs to be investigated, but indicates that DLX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROIC 2.11%
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
DLX.DE Yearly ROA, ROE, ROICDLX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 1.39%, DLX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Profit Margin of DLX has declined.
DLX has a worse Operating Margin (1.99%) than 75.00% of its industry peers.
DLX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 43.73%, DLX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
DLX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
DLX.DE Yearly Profit, Operating, Gross MarginsDLX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DLX is destroying value.
The number of shares outstanding for DLX remains at a similar level compared to 1 year ago.
DLX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DLX has been reduced compared to a year ago.
DLX.DE Yearly Shares OutstandingDLX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DLX.DE Yearly Total Debt VS Total AssetsDLX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 3.76 indicates that DLX is not in any danger for bankruptcy at the moment.
DLX has a Altman-Z score of 3.76. This is amongst the best in the industry. DLX outperforms 91.67% of its industry peers.
DLX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
DLX has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. DLX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.76
ROIC/WACC0.29
WACC7.25%
DLX.DE Yearly LT Debt VS Equity VS FCFDLX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.14 indicates that DLX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.14, DLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
DLX has a Quick Ratio of 1.86. This is a normal value and indicates that DLX is financially healthy and should not expect problems in meeting its short term obligations.
DLX has a Quick ratio of 1.86. This is amongst the best in the industry. DLX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 1.86
DLX.DE Yearly Current Assets VS Current LiabilitesDLX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The earnings per share for DLX have decreased strongly by -57.89% in the last year.
DLX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.22% yearly.
Looking at the last year, DLX shows a very negative growth in Revenue. The Revenue has decreased by -16.67% in the last year.
DLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.24% yearly.
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%

3.2 Future

DLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.22% yearly.
Based on estimates for the next years, DLX will show a quite strong growth in Revenue. The Revenue will grow by 8.13% on average per year.
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y8.13%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DLX.DE Yearly Revenue VS EstimatesDLX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
DLX.DE Yearly EPS VS EstimatesDLX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.25, DLX can be considered very expensive at the moment.
DLX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of DLX to the average of the S&P500 Index (26.26), we can say DLX is valued inline with the index average.
A Price/Forward Earnings ratio of 8.58 indicates a reasonable valuation of DLX.
Based on the Price/Forward Earnings ratio, DLX is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, DLX is valued rather cheaply.
Industry RankSector Rank
PE 29.25
Fwd PE 8.58
DLX.DE Price Earnings VS Forward Price EarningsDLX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DLX is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.89
DLX.DE Per share dataDLX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DLX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DLX's earnings are expected to grow with 44.23% in the coming years.
PEG (NY)1.07
PEG (5Y)N/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%

5

5. Dividend

5.1 Amount

DLX has a Yearly Dividend Yield of 2.29%.
DLX's Dividend Yield is comparable with the industry average which is at 3.28.
Compared to an average S&P500 Dividend Yield of 1.87, DLX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.29%

5.2 History

On average, the dividend of DLX grows each year by 11.75%, which is quite nice.
Dividend Growth(5Y)11.75%
Div Incr Years0
Div Non Decr Years0
DLX.DE Yearly Dividends per shareDLX.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2023 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%
DLX.DE Yearly Income VS Free CF VS DividendDLX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

DELIGNIT AG

FRA:DLX (12/18/2025, 7:00:00 PM)

2.34

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-26 2025-08-26
Earnings (Next)04-27 2026-04-27/amc
Inst Owners69.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.96M
Revenue(TTM)62.14M
Net Income(TTM)863.00K
Analysts84
Price Target6.12 (161.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.29%
Yearly Dividend0.08
Dividend Growth(5Y)11.75%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 29.25
Fwd PE 8.58
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.7
EV/EBITDA 4.89
EPS(TTM)0.08
EY3.42%
EPS(NY)0.27
Fwd EY11.65%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.07
BVpS3.62
TBVpS3.34
PEG (NY)1.07
PEG (5Y)N/A
Graham Number2.55
Profitability
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROCE 2.98%
ROIC 2.11%
ROICexc 2.64%
ROICexgc 2.9%
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
FCFM N/A
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
ROICexc(3y)7.91%
ROICexc(5y)8.19%
ROICexgc(3y)8.82%
ROICexgc(5y)9.23%
ROCE(3y)9.19%
ROCE(5y)9.93%
ROICexgc growth 3Y-25.04%
ROICexgc growth 5Y-10.87%
ROICexc growth 3Y-24.73%
ROICexc growth 5Y-10.11%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
F-ScoreN/A
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 1.86
Altman-Z 3.76
F-ScoreN/A
WACC7.25%
ROIC/WACC0.29
Cap/Depr(3y)125.11%
Cap/Depr(5y)92.99%
Cap/Sales(3y)3.97%
Cap/Sales(5y)3.03%
Profit Quality(3y)140.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y8.13%
EBIT growth 1Y-53.75%
EBIT growth 3Y-22.99%
EBIT growth 5Y-7.31%
EBIT Next Year160%
EBIT Next 3Y71%
EBIT Next 5Y54.93%
FCF growth 1Y-37.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3YN/A
OCF growth 5Y21.67%

DELIGNIT AG / DLX.DE FAQ

What is the fundamental rating for DLX stock?

ChartMill assigns a fundamental rating of 5 / 10 to DLX.DE.


What is the valuation status for DLX stock?

ChartMill assigns a valuation rating of 5 / 10 to DELIGNIT AG (DLX.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DELIGNIT AG?

DELIGNIT AG (DLX.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for DLX stock?

The financial health rating of DELIGNIT AG (DLX.DE) is 6 / 10.